CD274 and neoplasm: Rugo et al. analysed the programmed death ligand 1(PD‐L1)'s expression levels in ER+ tumours and only 20% of patients expressed PD‐L1, and single‐agent immune checkpoint inhibitors (ICIs) had limited efficacy in ER+, PD‐L1‐positive tumours.75